BioMarin Completes Alesta Therapeutics Acquisition, Adding HPP Drug Candidate ALE1

BioMarin Pharmaceutical Inc. has completed its previously announced acquisition of Alesta Therapeutics, adding clinical-stage drug candidate ALE1 to its portfolio... Read More

The post BioMarin Completes Alesta Therapeutics Acquisition, Adding HPP Drug Candidate ALE1 appeared first on citybiz.